Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy
July 1, 2026
Online First (2026)
https://doi.org/10.6004/jadpro.2026.17.7.22
5 Topic Commentaries
Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy
Fumiko Chino, MD
Radiation Oncology
•The University of Texas MD Anderson Cancer Center
John V. Cox, DO, MBA, FACP, FASCO
Medical Oncology
•UT Southwestern Medical Center
Ross L. Levine, MD
Hematologic Oncology (Myeloproliferative Neoplasms)
•Memorial Sloan Kettering Cancer Center
Tracelyn Freeman, PharmD, BCOP
Hematology/Oncology Pharmacy
•The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute
Scott A. Soefje, PharmD, RPh, MBA
Oncology Pharmacy
•Mayo Clinic Cancer Center
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.